0001213900-20-027375.txt : 20200918 0001213900-20-027375.hdr.sgml : 20200918 20200918163625 ACCESSION NUMBER: 0001213900-20-027375 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200916 FILED AS OF DATE: 20200918 DATE AS OF CHANGE: 20200918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZELDIS JEROME B CENTRAL INDEX KEY: 0001433982 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 201184363 MAIL ADDRESS: STREET 1: 8767 E. VIA DE VENTURA, SUITE 190 CITY: SCOTTSDALE STATE: AZ ZIP: 85258 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml OWNERSHIP DOCUMENT X0306 4 2020-09-16 0 0000812796 SOLIGENIX, INC. SNGX 0001433982 ZELDIS JEROME B 29 EMMONS DRIVE, SUITE B-10 PRINCETON NJ 08540 1 0 0 0 Stock Option (Right to Buy) 1.97 2020-09-16 4 A 0 15228 0 A 2030-09-15 Common Stock 15228 15228 D The stock option vests ratably on each of December 16, 2020, March 16, 2021, June 16, 2021 and September 16, 2021. /s/ Jermone B. Zeldis 2020-09-18